Lifespan Cancer Institute at Rhode Island Hospital /ID# 257693 is a clinical research site located in Providence, Rhode Island, United States 02903-4923.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Lifespan Cancer Institute at Rhode Island Hospital /ID# 257693 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers.
Sponsors: AbbVie.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lifespan Cancer Institute at Rhode Island Hospital /ID# 257693 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lifespan Cancer Institute at Rhode Island Hospital /ID# 257693 has 1 clinical trials on record, with 1 currently active. Their work covers Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers.
Lifespan Cancer Institute at Rhode Island Hospital /ID# 257693 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.